Credit Suisse’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $5.75M | Sell |
389,135
-2,483
| -0.6% | -$34.4K | 0.01% | 1219 |
|
|
2023
Q4 | $5.59M | Buy |
391,618
+3,538
| +0.9% | +$50.2K | 0.01% | 1268 |
|
|
2023
Q3 | $5.41M | Sell |
388,080
-347
| -0.1% | -$4.44K | 0.01% | 1227 |
|
|
2023
Q2 | $4.57M | Buy |
388,427
+24,314
| +7% | +$277K | ﹤0.01% | 1393 |
|
|
2023
Q1 | $4.19M | Sell |
364,113
-19,353
| -5% | -$239K | ﹤0.01% | 1432 |
|
|
2022
Q4 | $4.77M | Buy |
383,466
+89,049
| +30% | +$1.14M | 0.01% | 1334 |
|
|
2022
Q3 | $3.86M | Sell |
294,417
-4,598
| -2% | -$67.9K | ﹤0.01% | 1417 |
|
|
2022
Q2 | $4.18M | Sell |
299,015
-101,400
| -25% | -$1.36M | ﹤0.01% | 1406 |
|
|
2022
Q1 | $5.96M | Sell |
400,415
-33,268
| -8% | -$455K | 0.01% | 1345 |
|
|
2021
Q4 | $5.87M | Buy |
433,683
+5,934
| +1% | +$84K | ﹤0.01% | 1898 |
|
|
2021
Q3 | $6.3M | Sell |
427,749
-12,139
| -3% | -$205K | ﹤0.01% | 1870 |
|
|
2021
Q2 | $8.01M | Buy |
439,888
+6,987
| +2% | +$124K | ﹤0.01% | 1717 |
|
|
2021
Q1 | $7.51M | Sell |
432,901
-70,998
| -14% | -$1.25M | ﹤0.01% | 1777 |
|
|
2020
Q4 | $8.75M | Buy |
503,899
+96,974
| +24% | +$1.55M | ﹤0.01% | 1675 |
|
|
2020
Q3 | $5.61M | Sell |
406,925
-14,591
| -3% | -$214K | ﹤0.01% | 1722 |
|
|
2020
Q2 | $6.08M | Buy |
421,516
+73,967
| +21% | +$972K | ﹤0.01% | 1587 |
|
|
2020
Q1 | $3.79M | Buy |
347,549
+4,716
| +1% | +$87K | ﹤0.01% | 1712 |
|
|
2019
Q4 | $7.32M | Sell |
342,833
-68,732
| -17% | -$1.54M | 0.01% | 1607 |
|
|
2019
Q3 | $9.45M | Buy |
411,565
+12,928
| +3% | +$276K | 0.01% | 1341 |
|
|
2019
Q2 | $7.85M | Buy |
398,637
+17,002
| +4% | +$331K | 0.01% | 1462 |
|
|
2019
Q1 | $7.43M | Sell |
381,635
-1,674
| -0.4% | -$31.7K | 0.01% | 1423 |
|
|
2018
Q4 | $6.32M | Sell |
383,309
-18,846
| -5% | -$379K | 0.01% | 1426 |
|
|
2018
Q3 | $9.3M | Sell |
402,155
-39,034
| -9% | -$884K | 0.01% | 1298 |
|
|
2018
Q2 | $9.59M | Sell |
441,189
-25,037
| -5% | -$489K | 0.01% | 1264 |
|
|
2018
Q1 | $8.23M | Buy |
466,226
+5,900
| +1% | +$104K | 0.01% | 1363 |
|
|
2017
Q4 | $8.64M | Buy |
460,326
+15,403
| +3% | +$306K | 0.01% | 1379 |
|
|
2017
Q3 | $9.76M | Buy |
444,923
+314,059
| +240% | +$7.1M | 0.01% | 1262 |
|
|
2017
Q2 | $3.15M | Sell |
130,864
-29,113
| -18% | -$740K | ﹤0.01% | 1915 |
|
|
2017
Q1 | $4.47M | Sell |
159,977
-79,148
| -33% | -$2.08M | ﹤0.01% | 1735 |
|
|
2016
Q4 | $5.84M | Buy |
239,125
+87,190
| +57% | +$2M | 0.01% | 1546 |
|
|
2016
Q3 | $3.83M | Sell |
151,935
-62,228
| -29% | -$1.49M | ﹤0.01% | 1860 |
|
|
2016
Q2 | $4.42M | Buy |
214,163
+49,903
| +30% | +$1.04M | ﹤0.01% | 1716 |
|
|
2016
Q1 | $3.3M | Buy |
164,260
+6,557
| +4% | +$126K | ﹤0.01% | 1819 |
|
|
2015
Q4 | $3.19M | Buy |
157,703
+2,576
| +2% | +$54.3K | ﹤0.01% | 1936 |
|
|
2015
Q3 | $3.6M | Buy |
155,127
+18,391
| +13% | +$469K | ﹤0.01% | 1816 |
|
|
2015
Q2 | $3.52M | Buy |
136,736
+41,911
| +44% | +$1.19M | ﹤0.01% | 2055 |
|
|
2015
Q1 | $3.14M | Sell |
94,825
-71,148
| -43% | -$2.31M | ﹤0.01% | 2034 |
|
|
2014
Q4 | $5.04M | Buy |
165,973
+38,274
| +30% | +$1.05M | ﹤0.01% | 1749 |
|
|
2014
Q3 | $3.11M | Buy |
127,699
+39,904
| +45% | +$1.11M | ﹤0.01% | 2135 |
|
|
2014
Q2 | $2.52M | Buy |
87,795
+24,305
| +38% | +$706K | ﹤0.01% | 2529 |
|
|
2014
Q1 | $1.77M | Sell |
63,490
-3,388
| -5% | -$93.1K | ﹤0.01% | 2615 |
|
|
2013
Q4 | $1.75M | Sell |
66,878
-51,659
| -44% | -$1.33M | ﹤0.01% | 2788 |
|
|
2013
Q3 | $2.73M | Buy |
118,537
+67,938
| +134% | +$1.67M | ﹤0.01% | 2145 |
|
|
2013
Q2 | $1.32M | Buy |
+50,599
| New | +$1.46M | ﹤0.01% | 2583 |
|
Other funds holding SBRA
Credit Suisse's SBRA Position: Q1 2024 in Review
Credit Suisse reduced its Sabra Healthcare REIT (SBRA) stake by 0.63% in Q1 2024, selling an estimated $34.4K and leaving 389,135 shares worth $5.75M. The position accounts for 0.01% of the portfolio, ranked #1219.
Credit Suisse first reported a position in SBRA in Q2 2013 and has held it in 44 quarters since. The position peaked at $9.76M in Q3 2017. 342 funds tracked by Wall St. Rank hold SBRA as of Q1 2024.
- Credit Suisse held 389,135 shares of Sabra Healthcare REIT worth $5.75M as of Q1 2024.
- Credit Suisse sold 2,483 Sabra Healthcare REIT shares in Q1 2024, an estimated $34.4K.
- Sabra Healthcare REIT made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1219 holding.
- Credit Suisse first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Sabra Healthcare REIT position peaked at $9.76M in Q3 2017.
- 342 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.